Heart failure is a leading cause of death worldwide and is especially fatal for people who don’t have access to medical facilities. So, a team of researchers aims to bring heart failure screening from the lab to the home.
Enhertu wins two FDA breakthrough therapy designations – Pharmaceutical Technology
The ADC is already approved in different settings for patients with breast cancer, non-small cell lung cancer and gastroesophageal junction adenocarcinoma. Image credit: Shutterstock/Christoph Burgstedt.